肾小球疾病患者活动性结核发病率与危险因素:加拿大队列研究
该观察性队列研究利用加拿大不列颠哥伦比亚省肾脏病理登记库(2000-2012年)纳入3,079例成人肾小球疾病患者,中位随访6.2年。活动性结核发病率为197/10万人年,约为一般人群的23倍,且在所有肾小球疾病类型、移民状态及免疫抑制暴露与否中均高。移民自高发病率国家、eGFR降低、蛋白尿水平较高、狼疮肾炎及使用免疫抑制与结核风险升高相关。
要点
- 肾小球疾病患者活动性结核发病率为197/10万人年,约为一般人群的23倍。
- 所有肾小球疾病类型、移民状态及免疫抑制暴露与否均观察到高发病率。
- 移民自高发病率国家、eGFR降低、蛋白尿较高、狼疮肾炎及免疫抑制与结核风险升高相关。
核心结论
- 肾小球疾病患者活动性结核发病率高,且不因疾病类型、人口学特征或免疫抑制使用而异。
- 需要前瞻性研究评估在该人群中筛查潜伏性结核感染的效用。
研究设计与样本
- 观察性队列研究,利用省级肾脏病理登记库(2000-2012年)识别3,079例成人肾小球疾病患者。
- 纳入IgA肾病、局灶节段性肾小球硬化、ANCA相关性肾小球肾炎、狼疮肾炎、膜性肾病、微小病变肾病或其他肾小球疾病患者。
- 暴露因素包括人口学特征、移民状态、合并症、免疫抑制使用、eGFR和蛋白尿。
- 活动性结核诊断通过行政数据链接确定,定义基于(1)配发1种或以上用于治疗活动性结核的独特药物组合,或(2)因活动性结核就诊或住院。
- 结核定义在外部队列中验证,该队列链接至BC省疾病控制中心省级结核登记库;使用年龄匹配的一般人群计算标准化发病率比;采用Cox比例风险回归分析识别活动性结核危险因素。
主要发现
- 活动性结核结局定义的敏感度为87.6%,特异度为99.5%。
- 中位随访6.2年期间,41例患者发生活动性结核,发病率为197/10万人年,约为一般人群的23倍,且高于定义高结核发病率阈值30/10万人年的6倍以上。
- 所有肾小球疾病均观察到高发病率(范围110-403/10万人),加拿大出生和外国出生患者中均高(范围124-424/10万人),免疫抑制暴露与未暴露患者分别为282/10万人 vs 147/10万人。
- 与较高结核风险相关的因素包括:移民自高发病率国家(HR 3.90 [95% CI 1.75-8.68])、eGFR降低(HR 2.81 [95% CI 1.18-6.69])、较高水平蛋白尿(HR 1.15 [95% CI 1.04-1.27])、狼疮肾炎(HR 2.79 [95% CI 1.37-5.68])及免疫抑制使用(HR 2.13 [95% CI 1.13-4.03])。
关键数值与推荐
- 活动性结核定义:配发1种或以上用于治疗活动性结核的独特药物组合,或因活动性结核就诊或住院。
- 高结核发病率阈值:30/10万人。
- 活动性结核结局定义敏感度87.6%,特异度99.5%。
临床怎么用
- 肾小球疾病患者活动性结核发病率高,临床需关注该人群结核风险。
- 移民自高发病率国家、eGFR降低、蛋白尿较高、狼疮肾炎及使用免疫抑制的患者结核风险更高。
- 前瞻性研究需评估在该人群中筛查潜伏性结核感染的效用。
局限性
- 事件数相对较少,导致风险估计存在不确定性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE & OBJECTIVE: Kidney failure is an established risk factor for active tuberculosis (TB) but the risk of TB has not been reported in specific kidney diseases. We sought to determine the incidence of and risk factors for active TB in patients with glomerular disease. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: A provincial kidney pathology registry (2000-2012) was used to identify 3,079 adult patients with IgA nephropathy, focal segmental glomerulosclerosis (FSGS), antineutrophil cytoplasmic antibody (ANCA)-related glomerulonephritis, lupus nephritis, membranous nephropathy, minimal change disease, or "other" glomerular diseases in British Columbia, Canada. EXPOSURE: Predictors included demographics, immigration status, comorbidities, immunosuppression use, estimated glomerular filtration rate (eGFR), and proteinuria. OUTCOME: A diagnosis of active TB was ascertained using administrative data linkages and defined based on (1) the dispensation of 1 or more unique combinations of medications used to treat active TB, or (2) physician or hospital visits for active TB. ANALYTICAL APPROACH: The definition of TB was validated in an external cohort linked to the Provincial TB registry at the BC Centre for Disease Control (BCCDC). Standardized incidence ratios were calculated using the age-matched general population. Risk factors for active TB were identified using Cox proportional hazards regression analysis. RESULTS: The sensitivity and specificity of the outcome definition of active TB were 87.6% and 99.5%, respectively. During a median follow-up of 6.2 years, 41 patients developed active TB with an incidence of 197 of 100,000 person-years, approximately 23 times as high as the general population and>6 times higher than the threshold of 30 per 100,000 used to define high TB incidence. A high incidence was observed in all glomerular diseases (range, 110-403 per 100,000), in both Canadian- and foreign-born patients (range, 124-424 per 100,000), and in patients exposed or not to immunosuppression (282 vs 147 per 100,000). Factors associated with higher TB risk included immigration from a high-incidence country (HR, 3.90 [95% CI, 1.75-8.68]), diminished eGFR (HR, 2.81 [95% CI, 1.18-6.69]), higher levels of proteinuria (HR, 1.15 [95% CI, 1.04-1.27]), lupus nephritis (HR, 2.79 [95% CI, 1.37-5.68]), and immunosuppression use (HR, 2.13 [95% CI, 1.13-4.03]). LIMITATIONS: A relatively low number of events contributed to uncertainty in risk estimates. CONCLUSIONS: Patients with glomerular disease have a high incidence of active TB irrespective of disease type, demographics, or use of immunosuppression. Prospective studies are needed to evaluate the utility of screening for latent TB infection in this population. PLAIN-LANGUAGE SUMMARY: Patients with kidney failure are at high risk of developing tuberculosis (TB), a major infection that can be prevented by identifying and treating patients who have had prior exposure to TB. The risk of TB in specific kidney diseases is unknown. In this Canadian study of 3,079 patients with glomerular disease, a group of autoimmune kidney conditions, the rate of TB was 23 times higher than in the general population. The rate was high irrespective of the use of immunosuppressive drugs or whether patients had immigrated to Canada from another country. These findings suggest that screening patients with glomerular disease for prior TB exposure may be beneficial; however, this needs to be evaluated in a prospective study.
引用
- Canney M, Gunning HM, Johnston JC, et al. Incidence of and Risk Factors for Active Tuberculosis Disease in Individuals With Glomerular Disease: A Canadian Cohort Study. Am J Kidney Dis. 2023. PMID: 37516296. doi:10.1053/j.ajkd.2023.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。